Abstract:Ling Tang, &ast Hui Wang, &ast Kangli Cao, &ast Yajuan Li, Tingting Li, Ying Huang, Yuanhong Xu Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuanhong Xu, Email Purpose: Klebsiella pneumoniae ( K. pneumoniae ) is a Gram-negative bacterium that is predominantly associated with liver abscesses in global diabetic patients. High levels of glucose in the surrounding of K. pneumonia increase its pathogenicity including capsular polysaccharide (CPS) and fimbriae. Other important virulent factors include outer membrane protein A (ompA) and regulator mucoid phenotype A (rmpA). The objective of this investigation was to elucidate the effects of high glucose on rmpA and ompA gene expression and serum resistance of K. pneumoniae causing liver abscess. Patients and Methods: The clinical history of 57 patients suffering from K. pneumoniae -caused liver abscesses (KLA) was acquired and their clinical and laboratory manifestations in the presence or absence of diabetes were analyzed. The antimicrobial susceptibility, serotypes, and virulence genes were tested. Clinical isolates of 3 serotype-K1 hypervirulent K. pneumoniae (hvKP) were used to detect the effect of exogenous high glucose on rmpA, ompA , and clbB genes expression, and bacterial serum resistance. Results: KLA patients with diabetes showed higher C-reactive protein (CRP) compared to non-diabetic KLA patients. Furthermore, the diabetic group showed increased incidences of sepsis and invasive infections, and their length of hospital stay was also prolonged. Pre-incubation of K. pneumoniae in high glucose (0.5%) concentration up-regulated rmpA, ompA , and clbB genes expression. However, cAMP supplementation, which was inhibited by environmental glucose, reversed the increase of rmpA and ompA in a cAMP-dependent manner. Moreover, hvKP strains incubated in high glucose also exhibited enhanced protection from serum killing. Conclusion: High glucose levels reflected by poor glycemic control has increased gene expression of rmpA and ompA in hvKP by the cAMP signaling pathway and enhanced its resistance to serum killing, thus providing a new and reasonable explanation for the high incidences of sepsis and invasive infections in KLA patients with diabetes. Keywords: Klebsiella pneumoniae , liver abscess, diabetes, rmpA , ompA , serum resistance Klebsiella pneumoniae after colonization (in its virulent state) crosses the intestinal-mucosal barrier and targets the liver through the portal vein system, subsequently causing K. pneumoniae -caused liver abscesses (KLA). K. pneumoniae is bacteria that predominantly contributes to pyogenic liver abscesses worldwide. 1 KLA is generically cryptogenic and frequently becomes complicated because of invasive infection to other organs due to K. pneumoniae virulence factors, which include, capsular serotype, rmpA , and aerobactin. 2 Because of invasive systemic infections, the KLA mortality rate equates to 10% within 30 days of hospitalization. 3 Unfortunately, the dramatically increased multi-drug resistance (MDR) of hyper-virulent K. pneumoniae (hvKP), especially resistance to carbapenems and third-generation cephalosporins, presents a great challenge for clinical treatment. KLA is accompanied by many chronic diseases. Studies have shown that diabetes mellitus is a concomitant condition in approximately 29.3–44.3% of liver abscess cases. 4,5 Hyperglycemia weakens the immune barrier and increases the susceptibility to hvKP infection by inhibiting phagocytosis 6 and neutrophil extracellular traps (NETs) generation, 7 reducing macrophages' function, 8 and impairing the bacteriolysis of antibodies and complement. 9 Poor glycemic control, also affects the pathogenicity of K. pneumoniae . Lee et al found that high glucose levels stimulated the biosynthesis of polysaccharide and gene expression of hvKP's cps , thereby increasing phagocytosis resistance and development of invasive syndrome. 10 Exogenous glucose can also activate the production of K. pneumoniae 's type 3 fimbriae. These functions are under the control of global modulator cyclic AMP (cAMP) receptor protein (CRP) and cAMP-CRP signaling pathway. 11 However, it is unknown if the expressions of other known pathogenic factors, for instance, the rmpA, ompA< -Abstract Truncated-

Glucose Induces Resistance to Polymyxins in High-Alcohol-Producing Klebsiella pneumoniae via Increasing Capsular Polysaccharide and Maintaining Intracellular ATP

Glucose-Induced Cyclic Lipopeptides Resistance in Bacteria Via ATP Maintenance Through Enhanced Glycolysis

Prevalence and mechanisms of fosfomycin resistance among KPC-producing <i>Klebsiella pneumoniae</i> clinical isolates in China

Exogenous Glucose Interferes with Antimicrobial-Mediated ROS Accumulation and Bacterial Death

Effects of exogenous glucose on Pseudomonas aeruginosa biofilm formation and antibiotic resistance

Klebsiella pneumoniae aggravates lung injury through ethanol production

Epidemiological Features and Impact of High Glucose Level on Virulence Gene Expression and Serum Resistance of Klebsiella pneumoniae Causing Liver Abscess in Diabetic Patients

Exogenous Alanine And/or Glucose Plus Kanamycin Kills Antibiotic-Resistant Bacteria.

Ampicillin-controlled Glucose Metabolism Manipulates the Transition from Tolerance to Resistance in Bacteria.

The role of integration host factor in biofilm and virulence of high-alcohol-producing Klebsiella pneumoniae

Klebsiella Pneumonia, One of Potential Chief Culprits of Non-Alcoholic Fatty Liver Disease: Through Generation of Endogenous Ethanol

Antibiotic resistance and epidemiological characteristics of polymyxin-resistant Klebsiella pneumoniae

Alkyl deoxyglycoside-polymyxin combinations against critical priority carbapenem-resistant gram-negative bacteria

Fructose promotes ampicillin killing of antibiotic-resistant Streptococcus agalactiae

Disulfiram Enhances the Activity of Polymyxin B Against Klebsiella pneumoniae by Inhibiting Lipid A Modification

Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae

High alcohol-producing Klebsiella pneumoniae causes fatty liver disease through 2,3-butanediol fermentation pathway in vivo

Metformin Reverses tmexCD1-toprJ1- and tet(A)-Mediated High-Level Tigecycline Resistance in K. pneumoniae

Three Klebsiella species as potential pathobionts generating endogenous ethanol in a clinical cohort of patients with auto-brewery syndrome: a case control study

Impact of Polymyxin Resistance on Virulence and Fitness among Clinically Important Gram-Negative Bacteria

Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane Integrity